Buscar resultados de ensayos clínicos
Parotid Diseases - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Evaluation of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Parotidectomy Surgery Condición: Parotid Diseases Fecha: 2014-11-04 Intervenciones: Procedure: Parotidectomy Surgical Intervention with the FMwand Surgical System |
Not yet recruiting |
Nombre del estudio: Gender and Opioid Consumption Condición: Postoperative; Parotitis Fecha: 2016-12-27 Intervenciones: Drug: postoperative morphine Postoperatively, A loading dose of morphine will be given in incremental do |
Recruiting |
Nombre del estudio: SPI-directed Analgesia for Vitreoretinal Surgeries Condición:
|
Not yet recruiting |
Nombre del estudio: Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants Condición: Epidemic Parotitis,Mumps Fecha: 2017-04-17 Intervenciones:
|
Recruiting |
Nombre del estudio: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine Condición:
|
Active, not recruiting |
Nombre del estudio: Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants Condición: Mumps Fecha: 2016-02-23 Intervenciones:
|
Completed |
Nombre del estudio: Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors Condición:
Fecha: 2015-08-17 Intervenciones: Behavioral: Facial exercises A series of self-administered facial movements and expressions. |
Active, not recruiting |
Nombre del estudio: Feasibility Study of MRI Imaging on Parotid Gland Stimulation Condición: Parotid Neoplasms Fecha: 2014-11-12 Intervenciones:
|
Completed |
Nombre del estudio: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age Condición: Measles; Mumps; Rubella Fecha: 2014-07-03 Intervenciones:
|
Completed |
Nombre del estudio: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older Condición:
Fecha: 2014-02-06 Intervenciones:
|